Subendocardial Viability Ratio in Hypertension
Recruiting · NCT06309511 · Observational (researchers observe without assigning treatment) · Lead sponsor: Istituto Auxologico Italiano
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The aim of the research is to evaluate the Subendocardial Viability Ratio (SEVR) in hypertensive patients, using non-invasive arterial tonometry, and to establish the influencing factors and the possibility of predicting cardiovascular morbidity and mortality in arterial hypertension. The SEVR will be evaluated on all patients belonging to the Arterial Hypertension Centers undergoing non-invasive arterial tonometry. The SEVR is calculated on the morphology of the central pressure wave as the ratio between the DPTI (diastolic pressure-time index), i.e. the area between the carotid pressure curve and the ventricular pressure curve during the diastolic phase, and the SPTI ( systolic pressure-time index), i.e. the area under the carotid pressure curve during the systolic phase. The SEVR will be correlated with the anthropometric and pathology variables which will be collected in an appropriate database.
Who can take part
Inclusion criteria
- Hypertension
Exclusion criteria
- Atrial fibrillation
Where it is running
5 locations listed.
- Unità Operativa Semplice Dipartimentale Ipertensione Arteriosa "Anna Maria Pirrelli", Università degli Studi di Bari "Aldo Moro". Policlinico Consorziale di Bari - Bari, Italy
- Istituto Auxologico Italiano IRCCS - Milan, Italy
- Medicina II Cardiovascolare, AUSL-IRCCS di Reggio Emilia - Reggio Emilia, Italy
- Dipartimento di Scienze Mediche, Chirurgiche e della Salute, Università degli studi di Trieste - Trieste, Italy
- Centro di Prevenzione e Cura dell'Ipertensione Arteriosa "Alessandro Filippi" - Mascalucia, Catania, Italy